Editorial
Published on 02 Mar 2023
Editorial: Biological drugs and biosimilars in autoimmune diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1168972
- 3,154 views
- 3 citations
Type at least 3 characters
1,417 articles
Original Research
Published on 01 Mar 2023
The impact of aspirin exposure prior to intensive care unit admission on the outcomes for patients with sepsis-associated acute respiratory failure
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1125611
- 2,790 views
- 7 citations
Original Research
Published on 01 Mar 2023
EGCG identified as an autophagy inducer for rosacea therapy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1092473
- 6,829 views
- 5 citations
Original Research
Published on 01 Mar 2023
Aspirin-triggered Resolvin D1 ameliorates activation of the NLRP3 inflammasome via induction of autophagy in a rat model of neuropathic pain
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.971136
- 3,725 views
- 9 citations
Editorial
Published on 28 Feb 2023
Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164723
- 1,248 views
Perspective
Published on 27 Feb 2023
Glycyrrhizin for treatment of CRS caused by CAR T-cell therapy: A pharmacological perspective
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1134174
- 2,210 views
- 2 citations
Original Research
Published on 24 Feb 2023
Resveratrol attenuates staphylococcal enterotoxin B-activated immune cell metabolism via upregulation of miR-100 and suppression of mTOR signaling pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1106733
- 3,890 views
- 10 citations
Original Research
Published on 23 Feb 2023
Establishment and application of a high-throughput screening model for cell adhesion inhibitors
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1140163
- 2,875 views
- 3 citations
Review
Published on 21 Feb 2023
Trained immunity in monocyte/macrophage: Novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1109576
- 9,071 views
- 7 citations
Original Research
Published on 20 Feb 2023
Protective effect of bioactive iridium nanozymes on high altitude-related hypoxia-induced kidney injury in mice
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1115224
- 3,036 views
- 5 citations
Review
Published on 16 Feb 2023
Natural products can modulate inflammation in intervertebral disc degeneration
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1150835
- 4,609 views
- 7 citations
Editorial
Published on 16 Feb 2023
Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1152326
- 1,944 views
Clinical Trial
Published on 16 Feb 2023
The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1080730
- 3,788 views
- 3 citations
Original Research
Published on 15 Feb 2023
Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1124240
- 4,697 views
- 11 citations
Original Research
Published on 15 Feb 2023
Dietary methionine restriction alleviates oxidative stress and inflammatory responses in lipopolysaccharide-challenged broilers at early age
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1120718
- 3,238 views
- 8 citations
Review
Published on 15 Feb 2023
TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1037925
- 16,709 views
- 38 citations